Nex Metals Explorations Ltd
ASX:NME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nex Metals Explorations Ltd
ASX:NME
|
AU |
|
S
|
Sanix Inc
TSE:4651
|
JP |
|
Medicskin Holdings Ltd
HKEX:8307
|
HK |
|
Aramark
NYSE:ARMK
|
US |
|
N
|
Neurizer Ltd
ASX:NRZ
|
AU |
Balance Sheet
Balance Sheet Decomposition
Nex Metals Explorations Ltd
Nex Metals Explorations Ltd
Balance Sheet
Nex Metals Explorations Ltd
| Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
5
|
3
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
5
|
3
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
5
|
3
|
1
|
1
|
0
|
5
|
2
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
|
| PP&E Net |
2
|
4
|
3
|
6
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| PP&E Gross |
2
|
4
|
3
|
6
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
8
N/A
|
8
+2%
|
4
-47%
|
7
+79%
|
9
+21%
|
5
-43%
|
3
-49%
|
2
-19%
|
2
-15%
|
1
-27%
|
1
-46%
|
0
-51%
|
1
+163%
|
1
+67%
|
2
+16%
|
1
-16%
|
1
-37%
|
1
-16%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
7
|
7
|
5
|
4
|
4
|
2
|
2
|
3
|
4
|
3
|
4
|
1
|
2
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
1
|
0
|
1
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
1
|
8
|
9
|
6
|
6
|
6
|
4
|
4
|
5
|
5
|
3
|
5
|
2
|
2
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+250%
|
1
+89%
|
1
+40%
|
10
+1 204%
|
9
-3%
|
6
-34%
|
6
-5%
|
6
+1%
|
4
-37%
|
4
+2%
|
5
+23%
|
5
+16%
|
3
-40%
|
5
+62%
|
2
-65%
|
2
+22%
|
2
-2%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
8
|
10
|
11
|
17
|
19
|
19
|
19
|
19
|
19
|
19
|
19
|
20
|
20
|
24
|
24
|
28
|
28
|
30
|
|
| Retained Earnings |
0
|
2
|
7
|
11
|
20
|
23
|
22
|
23
|
23
|
21
|
22
|
24
|
24
|
26
|
28
|
29
|
29
|
31
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
7
N/A
|
7
0%
|
4
-53%
|
7
+85%
|
1
N/A
|
4
-374%
|
4
+16%
|
4
-6%
|
4
-9%
|
2
+41%
|
3
-27%
|
4
-40%
|
4
-4%
|
2
+61%
|
4
-101%
|
0
+89%
|
1
-238%
|
1
-8%
|
|
| Total Liabilities & Equity |
8
N/A
|
8
+2%
|
4
-47%
|
7
+79%
|
9
+21%
|
5
-43%
|
3
-49%
|
2
-19%
|
2
-15%
|
1
-27%
|
1
-46%
|
0
-51%
|
1
+163%
|
1
+67%
|
2
+16%
|
1
-16%
|
1
-37%
|
1
-16%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
77
|
85
|
89
|
132
|
153
|
153
|
153
|
153
|
153
|
153
|
153
|
193
|
193
|
267
|
267
|
353
|
364
|
334
|
|